Lab
United Clinical Laboratories, INC
United Clinical Laboratories, INC was paid $1.58M by Medicaid between Jan 2018 and Mar 2021, across 118 billing codes. Its largest line is 87491, Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe — 9.4% of everything it billed.
33Billing provider infoUNITED CLINICAL LABORATORIES, INC
DUBUQUE, IA 52001
DUBUQUE, IA 52001
33aNPI1871596676assigned 05/24/2005
33bProvider typeClinical Medical Laboratory
28Total paid$1.58M
24GClaims107,240
24DCodes billed118
24AFirst – last monthJan 2018 – Mar 2021
Compared with peers
Next to other Clinical Medical Laboratory providers in Iowa
Rank by total paid#7 of 35
Median peer was paid$42K
This provider vs. median38×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 42,420 | $630K | |
| 2019 | 37,902 | $573K | |
| 2020 | 25,578 | $368K | |
| 2021 | 1,340 | $7K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 9.4% | 4,192 | 3,839 | $148K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 9.4% | 4,194 | 3,839 | $148K |
| 87507 | 8.0% | 330 | 294 | $127K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 5.8% | 331 | 300 | $92K |
| 80050 | General health panel | 4.8% | 1,806 | 1,637 | $76K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 3.8% | 1,326 | 682 | $59K |
| 88142 | 3.7% | 3,079 | 2,909 | $58K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 3.7% | 1,553 | 1,441 | $58K |
| 80053 | Comprehensive metabolic panel | 3.3% | 5,648 | 5,105 | $52K |
| 80061 | Lipid panel | 3.3% | 4,673 | 4,209 | $51K |
| 87081 | 3.1% | 7,707 | 7,091 | $49K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 2.9% | 1,288 | 1,218 | $47K |
106 more codes
| 87086 | Culture, bacterial; quantitative colony count, urine | 2.3% | 5,379 | $36K |
| 84443 | Thyroid stimulating hormone (TSH) | 2.2% | 2,735 | $35K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.2% | 1,485 | $34K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 2.1% | 1,386 | $33K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.1% | 5,016 | $32K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 1.9% | 1,532 | $31K |
| 87077 | 1.8% | 3,859 | $28K | |
| 86780 | 1.4% | 1,670 | $22K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.3% | 887 | $20K |
| 87186 | 1.2% | 2,569 | $19K | |
| 36415 | Collection of venous blood by venipuncture | 1.1% | 9,797 | $18K |
| 83036 | Hemoglobin; glycosylated (A1C) | 1.1% | 2,264 | $17K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.0% | 246 | $16K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,188 | $15K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 315 | $14K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 156 | $14K |
| 87070 | <1% | 1,557 | $13K | |
| 86696 | <1% | 593 | $11K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,675 | $11K |
| 86762 | <1% | 680 | $9K | |
| 87340 | <1% | 1,002 | $9K | |
| 87486 | <1% | 253 | $8K | |
| 87581 | <1% | 253 | $8K | |
| 86695 | <1% | 594 | $8K | |
| 82607 | <1% | 588 | $7K | |
| 82274 | <1% | 406 | $7K | |
| 87147 | <1% | 1,602 | $7K | |
| 84439 | <1% | 921 | $7K | |
| 86803 | <1% | 494 | $7K | |
| 87210 | <1% | 1,375 | $6K | |
| 86850 | <1% | 780 | $5K | |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | <1% | 1,662 | $5K |
| 84702 | <1% | 390 | $4K | |
| 86618 | <1% | 138 | $4K | |
| 84153 | <1% | 265 | $4K | |
| 87071 | <1% | 406 | $3K | |
| 86140 | <1% | 681 | $3K | |
| 85027 | <1% | 673 | $3K | |
| 85610 | <1% | 1,212 | $3K | |
| 83655 | <1% | 257 | $3K | |
| 87075 | <1% | 381 | $3K | |
| 86038 | <1% | 226 | $3K | |
| 82043 | <1% | 526 | $3K | |
| 83516 | <1% | 226 | $3K | |
| 83880 | <1% | 99 | $2K | |
| 87631 | <1% | 28 | $2K | |
| 87046 | <1% | 214 | $2K | |
| 81025 | <1% | 308 | $2K | |
| 81003 | <1% | 973 | $2K | |
| 86900 | <1% | 684 | $2K | |
| 87634 | <1% | 28 | $2K | |
| 86901 | <1% | 683 | $2K | |
| 83690 | <1% | 300 | $2K | |
| 81000 | <1% | 772 | $2K | |
| 87427 | <1% | 181 | $2K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 12 | $2K |
| 86403 | <1% | 177 | $2K | |
| 80164 | <1% | 186 | $2K | |
| 87040 | <1% | 173 | $2K | |
| 86665 | <1% | 90 | $2K | |
| 85018 | <1% | 701 | $1K | |
| 85652 | <1% | 578 | $1K | |
| 82570 | <1% | 318 | $1K | |
| 86706 | <1% | 144 | $1K | |
| 80076 | <1% | 169 | $1K | |
| 84481 | <1% | 76 | $1K | |
| 82947 | <1% | 404 | $1K | |
| 83721 | <1% | 124 | $1K | |
| 86738 | <1% | 79 | $1K | |
| 87807 | <1% | 89 | $1K | |
| 87185 | <1% | 250 | $987.33 | |
| 86677 | <1% | 82 | $909.36 | |
| 84460 | <1% | 261 | $886.25 | |
| 82565 | <1% | 288 | $800.63 | |
| 83735 | <1% | 127 | $794.68 | |
| 36416 | <1% | 378 | $778.72 | |
| 87045 | <1% | 104 | $768.68 | |
| 84450 | <1% | 235 | $741.44 | |
| 82728 | <1% | 62 | $708.18 | |
| 86664 | <1% | 45 | $652.50 | |
| 84466 | <1% | 58 | $601.66 | |
| 84132 | <1% | 235 | $591.13 | |
| 87015 | <1% | 109 | $549.51 | |
| 84146 | <1% | 36 | $534.43 | |
| 83540 | <1% | 101 | $504.09 | |
| 83970 | <1% | 12 | $453.09 | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 41 | $416.78 |
| 87493 | <1% | 15 | $369.53 | |
| 82670 | <1% | 13 | $360.47 | |
| 81001 | <1% | 140 | $339.59 | |
| 82746 | <1% | 34 | $309.03 | |
| 85004 | <1% | 172 | $300.37 | |
| 82150 | <1% | 42 | $269.32 | |
| 83001 | <1% | 24 | $261.48 | |
| 82784 | <1% | 14 | $226.83 | |
| 86430 | <1% | 29 | $172.37 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 62 | $125.00 |
| 87205 | <1% | 28 | $112.96 | |
| 84295 | <1% | 35 | $89.08 | |
| 82550 | <1% | 16 | $83.28 | |
| 86592 | <1% | 15 | $60.12 | |
| 85014 | <1% | 12 | $13.85 | |
| 86481 | <1% | 31 | $1.50 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 0% | 15 | $0.00 |
| 0097U | 0% | 15 | $0.00 | |
| 0100U | 0% | 87 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialVANDERHEYDEN, ANDREW (MEDICAL DIRECTOR)